Condition
Focal Onset Seizure clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Focal Onset Seizure clinical trials that are recruiting, at sites in 3 countries (most in United States (2), Australia (1), Spain (1)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 3Countries
All recruiting trials (2)
-
Long-term RAP-219 treatment for adults with focal onset seizures
This trial will try RAP-219, an investigational anti-seizure medication, in adults with refractory focal seizures to see if it is safe long-term and helps reduce seizures.
-
Evaluating PRAX-628 for treating focal onset and tonic-clonic seizures in adults
This study is testing a new medication called PRAX-628 to see if it can help adults with focal onset or tonic-clonic seizures better control their symptoms while they are already on other seizure medications.
Related topics
Quick answers
How many Focal Onset Seizure clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (2 trials), Australia (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.